Cargando…
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
Minimal residual disease (MRD) has been increasingly investigated in mantle cell lymphoma (MCL), including for individual therapeutic stratification and pre-emptive treatment in clinical trials. Although patient/allele specific real-time quantitative polymerase chain reaction (qPCR) of IGH or BCL1-I...
Autores principales: | Drandi, Daniela, Alcantara, Marion, Benmaad, Ichrafe, Söhlbrandt, Arian, Lhermitte, Ludovic, Zaccaria, GianMaria, Ferrante, Martina, Genuardi, Elisa, Mantoan, Barbara, Villarese, Patrick, Cheminant, Morgane, Starza, Irene della, Ciabatti, Elena, Bomben, Riccardo, Jimenez, Cristina, Callanan, Mary, Abdo, Chrystelle, Eckert, Cornelia, Ribrag, Vincent, Cortelazzo, Sergio, Dreyling, Martin, Hermine, Olivier, Delfau-Larue, Marie-Hélène, Pott, Christiane, Ladetto, Marco, Ferrero, Simone, Macintyre, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162081/ https://www.ncbi.nlm.nih.gov/pubmed/32309784 http://dx.doi.org/10.1097/HS9.0000000000000347 |
Ejemplares similares
-
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network
por: Mantoan, Barbara, et al.
Publicado: (2021) -
P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERTOIRE IN MANTLE CELL LYMPHOMA: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III MCL0208 TRIAL.
por: Alessandria, B., et al.
Publicado: (2022) -
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma
por: Ferrero, Simone, et al.
Publicado: (2022) -
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial
por: Zaccaria, Gian Maria, et al.
Publicado: (2021) -
Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial
por: Genuardi, Elisa, et al.
Publicado: (2021)